EnsoData is partnering with Nonin, a provider of pulse oximetry devices, to address the underserved and undiagnosed sleep apnea patient population with a collaborative Type IV testing approach, the company announced recently.

According to a release, the partnership will combine the recently FDA-cleared EnsoSleep PPG software as a medical device algorithm with Nonin’s WristOx2 Model 3150 reusable wrist-worn device, offering sleep labs a way to test for sleep apnea at home.

“This partnership is an important step toward increasing patient access to quality sleep care,” EnsoData CEO Justin Mortara said in a statement. “As a trusted manufacturer of high-quality pulse oximetry solutions, Nonin’s devices provide more innovative hardware options for our customers to use in conjunction with EnsoSleep PPG. We are excited to launch this collaboration and continue to grow the EnsoData network of sleep medicine partnerships.”

Financial terms of the partnership were not disclosed.